Does Sunlight Exposure Improve Survival in Patients with Non-small Cell Lung Cancer?

Abstract

Background: Some epidemiological studies reported that sunlight exposure and highvitamin D levels may decrease the morbidity and mortality related to cancer. We aimed to evaluate whether sunlight exposure has an impact on survival in patients with non small cell lung cancer. Materials and Methods: A total of 546 patients with NSCLC from two different regions (Kayseri and Adana) differing according to sunlight exposure were analysed retrospectively. Results: The median overall survival (OS) rates were 11. 6 (CI: 9.50-13.6) and 15.6 months (CI: 12.4-18.8) for Kayseri and Adana, respectively, in all patients (p=0.880). Conclusions: There were no differences between groups in terms of OS. While there is strong evidence regarding inverse relationship between cancer incidence and sunlight exposure, it is still controversial whether sunlight exposure is a good prognostic factor for survival in patients with lung cancer.

Expression of ERCC1, RRM1 and LRP in Non-small Cell Lung Cancers and their Influence on Chemotherapeutic Efficacy of Gemcitabine Concomitant with Nedaplatin

“…Lung cancers rank the top of cancer-related death with increasing morbidity around the world (Aydiner et al, 2013;Cai et al, 2013;Kaya et al, 2013;Mutlu et al, 2013;Natukula et al, 2013;Oven et al, 2013;Unal et al, 2013;Wang et al, 2013). At present, the chemotherapeutic protocols for NSCLC mainly apply platinums as basic drugs combining with the third generation chemotherapeutic drugs such as paclitaxel, gemcitabine and vinorelbine, etc..…”

Fangchinoline inhibits the proliferation of SPC-A-1 lung cancer cells by blocking cell cycle progression

“…It has been reported that there were 239,320 new cases of lung cancer and 161,250 cases of mortality from lung cancer in the USA in 2010 (1). Although surgical excision, chemotherapy, radiation and targeted therapy have been applied to the treatment of lung cancer, the five-year survival rate remains at ~15.6%; thus, improved therapies for the treatment of NSCLC are urgently required (1,2). Traditional Chinese herbs are considered to be a good source for the identification of novel anti-cancer agents (3).…”